TRPM2 and neoplasm: In a neuroblastoma study, it was found that the expression of HIF-1/2α in TRPM2-S-expressing tumor cells was significantly decreased and that the reduction in the survival of TRPM2-S-expressing cells could be rescued by functional enhancement of HIF-1α or HIF-2α.